Prevent Cancer Foundation welcomes largest-ever Corporate Membership Program cohort in 2026
即時リリース
キラ・マイスター
703-836-1746
kyra.meister@preventcancer.org
Alexandria, Va. – The Prevent Cancer Foundation® is proud to welcome 23 leading companies to its Corporate Membership Program. Together, they make up the program’s largest-ever cohort, strengthening a growing network of business leaders dedicated to reducing the impact of cancer through prevention and early detection.
Program members receive exclusive access to Foundation events and resources while providing vital support for the Foundation’s work in education, outreach, advocacy and community. Through collaboration and the exchange of ideas, members help advance cancer prevention and early detection efforts, empowering people to take steps that can improve health outcomes and save more lives.
“Our corporate partners play a vital role in advancing cancer prevention and early detection nationwide,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “We’re proud to work alongside companies that share our vision of a world where cancer is preventable, detectable and beatable for all.”
The 2026 class of corporate members, as of the date of this publication, include:
Silver members
- Abbott
- ブリストル マイヤーズ スクイブ
- ホロジック
- ファイザー
- 製薬工業協会
Bronze members
- AbbVie
- Astellas
- AstraZeneca
- Boehringer Ingelheim
- エーザイ
- Eli Lilly & Co
- Exelixis
- フリーノム
- ジェネンテック
- Geneoscopy
- GSK
- ガーダントヘルス
- メルク
- Mercy BioAnalytics
- Natera
- ノバルティス
- サノフィ
The Corporate Membership Program is open to companies who support the Foundation’s mission: Stopping Cancer. Saving Lives. To learn more or inquire about joining, contact Anne Potter, Senior Director of Corporate and Foundation Relations, at anne.potter@prevencancer.org.
###
がん予防財団について®
がん予防財団® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, advocacy and community, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
当財団は、2035 年までにがんによる死亡者数を 40% 削減するという課題に立ち向かうべく立ち上がっています。この目標を達成するために、当財団は、がんを早期に発見し、複数のがんのスクリーニングを進めるための革新的な技術に $20 百万ドル、医療サービスが行き届いていないコミュニティへのがんスクリーニングとワクチン接種のアクセス拡大に $10 百万ドル、スクリーニングとワクチン接種の選択肢について一般の人々を啓蒙するために $10 百万ドルを投資することを約束しています。
詳細については、 がん予防.